FOLH1 and prostate neoplasm: We observed trends toward lower PSMA H-scores in liver metastases (mean, 66; range, 0–200) and higher PSMA levels in adrenal (mean, 118; range, 0–200) and prostate tumors (mean, 106; range, 0–200) compared with bone sites (vertebral and nonvertebral combined; mean, 88; range, 0–200; P = 0.001 and P = 0.02, respectively), when including all molecular subtypes (Figure 2E).